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Accepted for publication 30 29 The blots were probed with the link protein specific monoclonal antibody 9/30/8A4 and the aggrecan Gl and G2 domain specific antibody 12/21/1C6 (Developmental Hybridoma Bank). Purified link protein was used in mononuclear cell proliferation assays after sterile filtration through a 0-2 ,um pore size membrane. Link protein solutions were stored at 4°C and the protein concentration was determined using the bicinchoninic assay (BCA) for protein (Pierce).
Because the link protein preparation contained MOPS, the effect of MOPS upon T cell proliferation was investigated. MOPS was not found to be generally inhibitory to mitogen (concanavalin A (con A)) or antigen (purified protein derivative (PPD) or tetanus toxin) driven proliferation at concentrations less than 300 ,umol/l (data not shown). Nevertheless, those individuals (four of 96) with a high sensitivity to MOPS mediated inhibition, as demonstrated by a significantly reduced stimulation index in the presence of MOPS, were removed from the study.
Bovine showing positive responses were compared using Fischer's exact test. Second, by taking the natural logarithm of the SIs in the control population, it was possible to define a range of values which did not significantly differ from a normal distribution, and to calculate an upper limit for this range (defined as 2 SD above the mean of the transformed values). The number of patients and controls with SIs greater than this value were then compared. The SI of PBMC and SFMC (in those from whom synovial fluid could be obtained) were compared using the paired t test.
Results
Enhanced T cell proliferative responses to link protein, defined as an SI value> 1-50, were given by the PBMC of 26% of the RA patients tested-a significantly greater proportion (p < 0 05 by Fischer's exact test) than in the non-arthritic control group, of whom fewer than 10% showed increased responses (table 1) . Table 2 shows the range of stimulation indices in patients and controls. The distribution of the natural logarithm of SI values in normal controls did not vary substantially from normal (x2, p = 0A409), with a mean of 008 (SD 0A42). An upper limit on the control reference range was set 2 SD above the mean, which corresponded to an SI value of 2-5 (95% confidence interval 2-1 to 3 2). Only one of the SI values of the patient group and two of those from the controls fell outside the reference range.
In those 17 patients from whom synovial fluid was obtained, eight (47%) had SI values [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] . None of the patients tested (table 1) showed increased SI values, whereas a high proportion of RA patients (eight of nine) and non-arthritic controls (seven of seven) showed increased responses to intact hsp65.
Neither the frequency nor the magnitude of increased responses to link protein appeared to be correlated with the duration or severity of the disease, or to the age or gender of the patient. There was no significant difference in the response of patients and controls to mitogen or control antigen.
Discussion
We have previously found that antibodies to link protein were present in the serum of patients with RA, but not at significantly greater frequency or titre than in control individuals. 27 In the present study we have shown that a greater proportion of RA patients have peripheral blood derived T cells reactive to link protein (defined as an SI of 1.5 or greater) than non-arthritic individuals. The frequency of such responses was greater still in synovial fluid derived T cells. However, as the SI values for PBMC for all but one of the patients fell within the control range, it was not posible to show a relationship between the magnitude of these responses and the presence of RA. It seems likely that sub-groups of both RA patients and controls show weak T-cell proliferative responses to link protein.
Evidence from adjuvant induced arthritis had led to the hypothesis that molecular mimicry between mycobacterial heat shock proteins and cartilage proteoglycan could lead to autoimmune responses and arthritis. '9 30 In the adjuvant arthritis model, T cell cloning gave rise to both arthritogenic (A2b) and protective (A2c) T cell clones which recognised the same epitope (AA 180-188 Cellular immunity to link protein may play a role in the initiation or maintenance of the chronic inflammatory response in at least some RA patients, though it is difficult to distinguish if such immune responses are causal or a result of the destructive process. Articular cartilage is believed to be an immunologically privileged site and the continual, often aggressive erosion of cartilage in patients with RA may release novel matrix epitopes able to elicit secondary immune responses to a wide range of matrix components. It has been shown that the level of release of hyaluronan binding region into synovial fluid is much greater in RA patients with advanced cartilage degeneration than in those with little or no cartilage damage.33 It is also possible that such epitopes are released during cartilage damage unrelated to the presence of inflammatory arthritis, including that caused by degenerative arthritis or by trauma, which may explain the presence of T cells responsive to link protein in the control population. Fragments from proteoglycans and associated matrix components may be cross reactive with pathological organisms, or altered antigen processing may result in the presentation of cryptic epitopes to T cells, as has been observed in the Balb/c mouse model of proteoglycan induced arthritis. 34 Further work on the processing of proteoglycans by cells from RA patients and normal individuals and mapping T cell epitopes on these antigens is needed to determine the relevance of our findings. 
